| Breast Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived183 of 183show fewer |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 149 trials (80 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 144 trials (64 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 144 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 129 trials (40 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 118 trials (58 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 118 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 103 trials (39 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 72 trials (34 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 65 trials (26 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 55 trials (22 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 55 trials (28 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 54 trials (26 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 39 trials (17 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 34 trials (25 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 33 trials (10 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 30 trials (13 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 28 trials (12 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 27 trials (9 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 27 trials (14 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 26 trials (14 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 24 trials (12 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 24 trials (15 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 23 trials (9 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 22 trials (11 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 20 trials (10 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 15 trials (10 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aromatase Inhibitor 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afimoxifenesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Birabresibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 7-Ethyl-10-Hydroxycamptothecinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imlunestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lasofoxifenesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Patritumab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumab/Trastuzumab Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PI3Kbeta Inhibitor AZD8186 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pictilisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rebastinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Repotrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retaspimycin Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selective Estrogen Receptor Covalent Antagonist H3B-6545 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxane Compound 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triciribinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |